<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Contrast echocardiography: Clinical applications
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Contrast echocardiography: Clinical applications
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Contrast echocardiography: Clinical applications
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Hanna Ahmed, MD, MPH, FACC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Warren J Manning, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan B Yeon, MD, JD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 27, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Contrast echocardiography is a technique in which use of an ultrasound-enhancing agent (UEA) improves the diagnostic performance of echocardiography [
         <a href="#rid1">
          1
         </a>
         ]. The term UEA is used to describe these agents to distinguish these from radiographic iodinated contrast agents and magnetic resonance gadolinium-based contrast agents [
         <a href="#rid2">
          2
         </a>
         ]. The clinical applications of contrast echocardiography will be reviewed here. Safety and optimization of the echocardiographic settings for UEAs are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5301.html" rel="external">
          "Contrast echocardiography: Contrast agents, safety, and imaging technique"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          AGITATED SALINE CONTRAST
         </span>
         <span class="headingEndMark">
          —
         </span>
         Agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast is administered intravenously to serve as a contrast agent for the right heart and for intracardiac shunt detection.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Shunt detection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         is well suited for detection of intracardiac or transpulmonary shunts since the air microbubbles do not cross the pulmonary circulation due to their size and short half-life. Commercially available UEAs that traverse the pulmonary vasculature (such as Definity [
         <a class="drug drug_general" data-topicid="10142" href="/z/d/drug information/10142.html" rel="external">
          perflutren lipid microspheres
         </a>
         ], Lumason [
         <a class="drug drug_general" data-topicid="97563" href="/z/d/drug information/97563.html" rel="external">
          sulfur hexafluoride lipid microspheres
         </a>
         ], and Optison [
         <a class="drug drug_general" data-topicid="10335" href="/z/d/drug information/10335.html" rel="external">
          perflutren protein type A
         </a>
         ]) are
         <strong>
          not
         </strong>
         designed for shunt detection.
        </p>
        <p class="headingAnchor" id="H1247074823">
         <span class="h3">
          For intracardiac or pulmonary arteriovenous shunts
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Use
         </strong>
         – Agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast is most often used to detect patent foramen ovale (PFO), atrial septal defects (ASDs), and pulmonary arteriovenous shunts.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Technique
         </strong>
         [
         <a href="#rid3">
          3
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A commonly used method is to connect two syringes to a three-way stopcock: one syringe with 9 or 10 mL of normal
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         and the other syringe with 1 mL of room air. Agitated saline solution is created by alternately flushing the contents of the two syringes into each other.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         solution is rapidly injected into an intravenous line connected to a 20-gauge or larger intravenous catheter (generally in a large antecubital or forearm vein).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Echocardiographic harmonic imaging is centered on the interatrial septum with views of the right and left atria. Recording is started at least five beats prior to arrival of agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast in the right atrium and continued for at least 10 beats after agitated saline contrast arrival in the right atrium.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The above agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         injection procedure and imaging is performed at rest (with no maneuvers), as the patient coughs (at the time of arrival of agitated saline in the right atrium), and as the patient releases a Valsalva (which is achieved by asking the patient to perform that Valsalva maneuver during saline agitation and injection and then release the Valsalva when agitated saline appears in the right heart).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic findings
         </strong>
         – Visualization of air microbubbles in the left atrium (LA)/left ventricle (LV) after intravenous agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast injection and right atrial opacification with microbubbles suggests the presence of an intracardiac or transpulmonary shunt [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Early
         </strong>
         – The appearance of microbubbles in the LA or LV early (generally within three to five beats) after right heart opacification suggests an intracardiac shunt (ASD or PFO) [
         <a href="#rid3">
          3
         </a>
         ]. However, a sinus venosus ASD may result in LA opacification simultaneous with (or before) right atrial opacification [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1418.html" rel="external">
          "Clinical manifestations and diagnosis of atrial septal defects in adults", section on 'Transthoracic echocardiogram'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1420.html" rel="external">
          "Patent foramen ovale", section on 'Ultrasound techniques'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Late
         </strong>
         – Late appearance of bubbles in the LA or left heart (&gt;5 beats) after right heart opacification suggests transpulmonic passage. Identification of only a few late bubbles may indicate clinically unimportant transpulmonic shunting. Evaluation of pulmonary arteriovenous malformations is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8268.html" rel="external">
          "Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Accuracy
         </strong>
         – The sensitivity of the agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast test using transthoracic echocardiography (TTE) is routinely enhanced by performing the test multiple times, at rest and with provocative maneuvers (eg, Valsalva and cough) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The sensitivity of the test can be further enhanced, especially for detection of smaller shunts, with transesophageal echocardiography (TEE). However, some patients may have difficulty performing provocative maneuvers due to discomfort associated with the TEE probe and/or the effects of sedation for the TEE procedure. Abdominal compression maneuvers can be used in this situation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         False negatives can occur with inadequate right atrial opacification (caused by inadequate injection, brisk inferior vena cava flow, or limited transit of agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         to the area of the interatrial septum due to a large Eustachian valve), failure to raise right atrial pressure above LA pressure (caused by inadequate provocative maneuvers or elevated LA pressure) or failure to visualize bubbles (suboptimal acoustic windows or dislodged intravenous catheter) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         False positives for an intracardiac shunt (early bubbles in the LA) can occur in patients with very high output states or significant pulmonary arteriovenous shunting.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The best method to identify the location of intracardiac shunting is direct visualization of bubble passage, when possible [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In patients with continuous left to right flow across the ASD, a negative contrast effect (absence of agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast) may be seen in the right atrium adjacent to the ASD [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Coordination with color flow Doppler
         </strong>
         – If an ASD is clearly demonstrated by two-dimensional echocardiography with color flow Doppler, an agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast study is not required. The diagnostic evaluation of ASD is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1418.html" rel="external">
          "Clinical manifestations and diagnosis of atrial septal defects in adults", section on 'Diagnosis and evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Persistent left SVC
         </span>
         <span class="headingEndMark">
          —
         </span>
         The presence of a persistent left superior vena cava (SVC) draining into the coronary sinus (or into a pulmonary vein or directly into the LA) may complicate transvenous placement of a pulmonary artery (Swan-Ganz) catheter, pacemaker, or implantable cardioverter-defibrillator lead, as well as retrograde cardioplegia [
         <a href="#rid6">
          6
         </a>
         ]. This venous anomaly is usually detected incidentally.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          When to suspect left SVC
         </strong>
         – A persistent left SVC is suspected when a dilated coronary sinus is detected in the absence of a cause for elevated right atrial pressure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic findings
         </strong>
         – Following injection of agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast (or commercially available UEA) into a left arm vein, contrast appears in the coronary sinus before appearing in the right atrium [
         <a href="#rid7">
          7
         </a>
         ]. Upon intravenous injection of contrast into the right arm, there is normal transit of contrast with right atrial opacification before appearance of contrast in the coronary sinus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Associated cardiovascular anomalies are present in a minority of patients with persistent left SVC [
         <a href="#rid6">
          6,8
         </a>
         ]. Associated venous anomalies include absence of the innominate vein and, more rarely, absence of the right SVC or drainage of the left SVC into the LA.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3461749794">
         <span class="h3">
          Other shunts
         </span>
         <span class="headingEndMark">
          —
         </span>
         An agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast study may also identify shunt flow in patients with ventricular septal defect (VSD) or patent ductus arteriosus (PDA) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with VSDs, after agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast opacification of the right ventricle (RV), bubbles may appear in the LV before they appear in the LA. This is most likely to occur when there is pulmonary hypertension but may also occur without pulmonary hypertension due to transient alterations in the transventricular pressure [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with PDA and pulmonary hypertension, after agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         contrast opacification of the RV, bubbles may appear in the descending aorta (before they appear in the LA) without filling of the ascending aorta [
         <a href="#rid10">
          10-12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H138240054">
         <span class="h2">
          Doppler signal enhancement
         </span>
         <span class="headingEndMark">
          —
         </span>
         Agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         (or a commercially available UEA) may be used to enhance the tricuspid regurgitation continuous wave Doppler signal for estimation of RV systolic pressure. (See
         <a class="medical medical_review" href="/z/d/html/5292.html" rel="external">
          "Echocardiographic evaluation of the tricuspid valve", section on 'Contrast echocardiography'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83974.html" rel="external">
          "Echocardiographic assessment of the right heart", section on 'Pulmonary artery pressure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          COMMERCIALLY AVAILABLE UEAS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The three commercially available US Food and Drug Administration (FDA)-approved UEAs are all second-generation microsphere agents that traverse the pulmonary vasculature: Definity (Luminity in Europe;
         <a class="drug drug_general" data-topicid="10142" href="/z/d/drug information/10142.html" rel="external">
          perflutren lipid microspheres
         </a>
         ), Lumason (Sonovue outside the US; sulfur hexafluoride lipid microsphere), and Optison (
         <a class="drug drug_general" data-topicid="10335" href="/z/d/drug information/10335.html" rel="external">
          perflutren protein type A
         </a>
         ). Each of these agents is composed of a flexible shell containing a high molecular weight gas with low diffusivity and solubility to optimize stability [
         <a href="#rid2">
          2
         </a>
         ]. These agents traverse the pulmonary and systemic capillary beds (diameter range 1.1 to 4.5 micrometers) [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The only FDA-approved cardiac imaging indication for UEAs is for LV blood pool opacification via an intravenous injection. There are a number of off-label cardiac imaging uses for UEAs, which are also described below.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          REST ECHOCARDIOGRAPHY
         </span>
        </p>
        <p class="headingAnchor" id="H901564484">
         <span class="h2">
          Clinical use for rest echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         UEA contrast rest echocardiography is recommended in the following settings, as described in the 2018 American Society of Echocardiography guideline update [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ventricular imaging
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When two or more LV segments cannot be visualized adequately for the assessment of LV function (LV ejection fraction [LVEF] and regional wall motion [RWM]) and/or in settings in which the indication for the study requires accurate RWM analysis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When quantitative assessment of LVEF is important for prognosis or management of the clinical condition. Of note, biplane LV volumes obtained with UEAs are typically larger than those measured without UEAs, although the normal range for LVEF is the same.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When RV opacification (beyond what can be achieved with agitated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         ) is indicated to assess RV function, tumors, or thrombi.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         To identify or exclude post-myocardial infarction (MI) complications (including LV aneurysm, pseudoaneurysm, and thrombus) when noncontrast echocardiographic views are suboptimal.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When the structure of LV cardiomyopathies (noncompaction cardiomyopathy or apical hypertrophy with possible aneurysm) is not adequately visualized with noncontrast echocardiography. (See
         <a class="medical medical_review" href="/z/d/html/4924.html" rel="external">
          "Isolated left ventricular noncompaction in adults: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4947.html" rel="external">
          "Hypertrophic cardiomyopathy: Morphologic variants and the pathophysiology of left ventricular outflow tract obstruction", section on 'Apical HCM'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When LV thrombus cannot be effectively identified or excluded with noncontrast echocardiography [
         <a href="#rid13">
          13
         </a>
         ]. Causes of LV thrombus include MI (generally apical or posterolateral) and eosinophilic myocarditis. (See
         <a class="medical medical_review" href="/z/d/html/90.html" rel="external">
          "Left ventricular thrombus after acute myocardial infarction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2211.html" rel="external">
          "Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atrial imaging
         </strong>
         – When TEE assessment for left atrial appendage thrombus is suboptimal or reveals significant spontaneous contrast.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac masses
         </strong>
         – To identify and characterize cardiac masses (including use of very low mechanical index [VLMI] to assess vascularity).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Doppler signal
         </strong>
         – As mentioned earlier, UEAs can also be used to enhance Doppler signals (see
         <a class="local">
          'Doppler signal enhancement'
         </a>
         above). Since commercial UEAs pass into the left heart, they can be used to enhance both right heart (tricuspid) or left heart (mitral or aortic) signals for evaluation of diastolic or valvular function [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2354833831">
         <span class="h2">
          Rationale and evidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         UEA contrast echocardiography is an accurate and timely method for evaluating LV function, is particularly helpful for patients in settings (such as an intensive care unit) in which native TTE images are frequently suboptimal, and may reduce the need for TEE or other imaging modalities in such settings [
         <a href="#rid15">
          15
         </a>
         ]. Opacification of the LV cavity with a UEA enhances endocardial border detection, thus decreasing the variability in interpretation of RWM abnormalities, LV volumes, and LVEF  (
         <a class="graphic graphic_diagnosticimage graphicRef55017" href="/z/d/graphic/55017.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid2">
          2,14,16,17
         </a>
         ]. In approximately 5 to 20 percent of noncontrast echocardiographic studies, suboptimal images limit interpretation, thereby impairing the assessment of segmental and global LV systolic function [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         Second-generation microbubble contrast agents achieve LV opacification in 90 percent of cases in which baseline images are suboptimal [
         <a href="#rid19">
          19
         </a>
         ]. The success of this technique is dependent upon the intensity and homogeneity of contrast within the LV cavity. There are a variety of techniques that sonographers can use to optimize the image. (See
         <a class="medical medical_review" href="/z/d/html/5301.html" rel="external">
          "Contrast echocardiography: Contrast agents, safety, and imaging technique", section on 'Optimal echocardiographic settings'
         </a>
         .)
        </p>
        <p>
         A prospective study of 632 consecutive patients with technically difficult TTE studies evaluated the impact of contrast Definity (
         <a class="drug drug_general" data-topicid="10142" href="/z/d/drug information/10142.html" rel="external">
          perflutren lipid microspheres
         </a>
         ) enhancement on diagnosis and management [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         With UEA contrast, the percent of uninterpretable studies decreased from 11.7 to 0.3 percent, and technically difficult studies decreased from 86.7 to 9.8 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Without UEA contrast, an LV thrombus was suspected in 35 patients and definite thrombus was identified in three patients. With contrast, LV thrombus was suspected in only one patient and definite thrombus was identified in five patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         With UEA contrast, additional procedures were avoided in 32.8 percent of patients and drug management was altered in 10.4 percent, with some change in management in a total of 35.6 percent of patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The impact of UEA contrast increased with worsening quality of nonenhanced study, with greatest increment in quality seen in intensive care units.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          STRESS ECHOCARDIOGRAPHY
         </span>
        </p>
        <p class="headingAnchor" id="H4113219230">
         <span class="h2">
          Clinical use for stress echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stress echocardiography with a UEA is recommended in the following settings when resting noncontrast echocardiography does not provide adequate visualization for regional wall motion abnormalities (RWMA) within any coronary territory. (See
         <a class="medical medical_review" href="/z/d/html/5310.html" rel="external">
          "Overview of stress echocardiography"
         </a>
         .)
        </p>
        <p>
         Very low mechanical index (VLMI) imaging is the preferred imaging mode for stress echocardiography. For homogenous LV opacification, VLMI is used with intermittent flash high-mechanical index impulses (5 to 15 frames at a mechanical index of 0.8 to 1.0).
        </p>
        <p>
         UEA dosing protocols for stress echocardiography minimize acoustic shadowing and provide steady concentrations of microbubbles via infusions of dilute UEA (for Definity and Optison), or small bolus injections (for Definity, Lumason, or Optison) with slow
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         flushes.
        </p>
        <p>
         The potential off-label use of UEAs to detect myocardial perfusion is discussed below. (See
         <a class="local">
          'Future directions'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1407343618">
         <span class="h2">
          Rationale and evidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic accuracy (sensitivity and specificity) of exercise and pharmacologic stress echocardiography requires accurate assessment of LV segmental wall motion and thickening. Improved diagnostic accuracy with UEA contrast echocardiography compared with native imaging has led many laboratories to routinely use UEA contrast with stress imaging, particularly given the general challenges of postexercise imaging [
         <a href="#rid21">
          21,22
         </a>
         ].
        </p>
        <p>
         VLMI techniques enhance detection of RWMA and subendocardial wall thickening abnormalities.
        </p>
        <p>
         The efficacy of UEA contrast echocardiography for the assessment of LV wall motion abnormalities was evaluated in a retrospective multicenter study of 4011 patients with suboptimal native echocardiographic images who underwent
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         stress echocardiography with UEA for evaluation of suspected coronary artery disease (CAD) [
         <a href="#rid23">
          23
         </a>
         ]. Sensitivity and diagnostic accuracy for detection of significant CAD (defined as &gt;50 percent coronary artery stenosis by quantitative angiography) was compared with that obtained in 1923 matched patients with optimal images on stress echocardiography without use of a UEA contrast agent. Sensitivity and diagnostic accuracy were similar in the group with initially suboptimal images receiving UEA compared with those with optimal images without UEA (81 versus 73 percent and 82 versus 77 percent).
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          ALCOHOL SEPTAL ABLATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The off-label use of UEA to guide alcohol septal ablation as a treatment for outflow obstruction in patients with hypertrophic cardiomyopathy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4920.html" rel="external">
          "Hypertrophic cardiomyopathy: Management of patients with outflow tract obstruction", section on 'Septal reduction therapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2965292607">
         <span class="h1">
          FUTURE DIRECTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myocardial contrast echocardiography (MCE) is not an FDA-approved indication and clinical experience is limited. Studies of MCE have investigated its utility for detection of CAD and assessment of prognosis.
        </p>
        <p>
         When myocardial perfusion imaging with a UEA is combined with contrast assessment of wall motion abnormalities, the technique is referred to as real-time myocardial contrast echocardiography (RTMCE). Studies comparing RTMCE with standard contrast stress echocardiography (assessing wall motion only) have found that RTMCE may improve the accuracy of detection of obstructive CAD [
         <a href="#rid24">
          24-26
         </a>
         ] and may also have prognostic value [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective randomized comparison of RTMCE and standard contrast stress echocardiography among 2063 patients referred for stress echocardiography for suspected CAD, RTMCE identified more resting wall motion abnormalities (13 versus 9 percent) as well as significantly more abnormal stress tests (30 versus 22 percent) [
         <a href="#rid25">
          25
         </a>
         ]. An abnormal RTMCE more frequently resulted in revascularization than an abnormal standard contrast stress echocardiogram. Resting wall motion abnormalities seen with RTMCE were an independent predictor of death/nonfatal MI but resting wall motion abnormalities identified by standard contrast stress echocardiography were not.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective study of 788 patients who underwent
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         stress echocardiography with UEA contrast for RTMCE, 75 patients (9.6 percent) died or had a nonfatal MI at follow-up [
         <a href="#rid24">
          24
         </a>
         ]. Abnormal myocardial perfusion added significant incremental predictive value to clinical factors, resting LVEF, and wall motion abnormalities. The three-year event-free survival was 95 percent in patients with normal wall motion and myocardial perfusion, 82 percent with normal wall motion and abnormal myocardial perfusion, and 68 percent for abnormalities in both wall motion and myocardial perfusion.
        </p>
        <p>
        </p>
        <p>
         Studies have found that RTMCE (or myocardial perfusion imaging with UEA) correlates with regional tracer uptake in nuclear single photon emission computed tomography (SPECT) imaging for detection of CAD [
         <a href="#rid27">
          27-29
         </a>
         ]. The largest multicenter study included 516 patients, each of whom underwent radiographic coronary angiography,
         <a class="drug drug_general" data-topicid="9377" href="/z/d/drug information/9377.html" rel="external">
          dipyridamole
         </a>
         stress SPECT examination, and RTMCE using Lumason [
         <a href="#rid29">
          29
         </a>
         ]. Both SPECT and RTMCE were blindly interpreted by three separate experts, while coronary angiograms were assessed quantitatively. There was only fair agreement among the three experts. Thirty-one percent of patients had &gt;70 percent stenosis. RTMCE yielded superior sensitivity (75 versus 49 percent) to SPECT but inferior specificity (52 versus 81 percent, respectively). Similar results were obtained in subgroup analyses (single versus multivessel disease, prior MI, proximal disease, 50 percent stenosis).
        </p>
        <p class="headingAnchor" id="H189182">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Contrast echocardiography is a technique that uses ultrasound-enhancing agents (UEAs) to improve the diagnostic performance of echocardiographic studies. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Agitated
         </strong>
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         <strong>
          contrast
         </strong>
         – Agitated saline contrast is used to identify intracardiac shunts (particularly patent foramen ovale [PFO] and atrial septal defects [ASDs]), pulmonary arteriovenous shunts, and persistent left superior vena cava (SVC). It is also used to enhance tricuspid regurgitation continuous wave Doppler spectra for estimation of right ventricular (RV) systolic pressure. Agitated saline may be beneficial for both transthoracic echocardiographic (TTE) and transesophageal echocardiographic (TEE) studies. (See
         <a class="local">
          'Agitated saline contrast'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Commercially available UEAs
         </strong>
         – The commercially available UEAs are second-generation microsphere agents that traverse the pulmonary vasculature. The only US Food and Drug Administration (FDA)-approved cardiac imaging indication for these UEAs is for left ventricular (LV) blood pool opacification via intravenous injection. (See
         <a class="local">
          'Commercially available UEAs'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Rest transthoracic echocardiography
         </strong>
         – For rest TTE, commercially available UEAs are used to assess global and segmental left and right ventricular wall motion, to identify LV structural abnormalities (such as noncompaction cardiomyopathy, aneurysm, or pseudoaneurysm), to identify intracardiac thrombus/masses, and to enhance Doppler signals. (See
         <a class="local">
          'Rest echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Stress echocardiography
         </strong>
         – For stress echocardiography, commercially available UEAs are used to assess global and segmental LV wall motion at rest and with stress. Real-time myocardial contrast echocardiography (RTMCE) is an off-label use of UEA to detect myocardial perfusion, which may aid in the detection of myocardial ischemia and viability. (See
         <a class="local">
          'Stress echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alcohol septal ablation
         </strong>
         – The off-label use of UEA to guide alcohol septal ablation as a treatment for outflow obstruction in patients with hypertrophic cardiomyopathy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4920.html" rel="external">
          "Hypertrophic cardiomyopathy: Management of patients with outflow tract obstruction", section on 'Septal reduction therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Myocardial contrast echocardiography
         </strong>
         – Myocardial contrast echocardiography (MCE) is not an FDA-approved use of UEAs, and clinical experience is limited. Studies of MCE have investigated its utility for detection of coronary artery disease (CAD) and assessment of prognosis. (See
         <a class="local">
          'Future directions'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lindner JR. Contrast echocardiography: current status and future directions. Heart 2021; 107:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr 2018; 31:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard S, Churchill TW, Namasivayam M, Bertrand PB. Agitated Saline Contrast Echocardiography in the Identification of Intra- and Extracardiac Shunts: Connecting the Dots. J Am Soc Echocardiogr 2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 2015; 28:910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saric M, Armour AC, Arnaout MS, et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. J Am Soc Echocardiogr 2016; 29:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal SK, Punnam SR, Verma G, Ruberg FL. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound 2008; 6:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart JA, Fraker TD Jr, Slosky DA, et al. Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound 1979; 7:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webb WR, Gamsu G, Speckman JM, et al. Computed tomographic demonstration of mediastinal venous anomalies. AJR Am J Roentgenol 1982; 139:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jin S, Zhao S, Wan X, et al. A Positive Microbubble Study in Ventricular Septal Defect Patient Without Pulmonary Hypertension. JACC Case Rep 2023; 11:101782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar P, Sinha SK, Pandey U, et al. Patent Ductus Arteriosus With Eisenmenger Syndrome: Difficult Diagnosis Made Easily With Saline Contrast Echocardiography. Cardiol Res 2016; 7:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panetta C, Schiller N. Evidence of patent ductus arteriosus and right-to-left shunt by finger pulse oxymetry and Doppler signals of agitated saline in abdominal aorta. J Am Soc Echocardiogr 1999; 12:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang HF, Yang B, Lin Q, et al. Dynamic biomechanical effect of lower body positive pressure treadmill training for hemiplegic gait rehabilitation after stroke: A case report. World J Clin Cases 2021; 9:632.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine GN, McEvoy JW, Fang JC, et al. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation 2022; 146:e205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 2008; 21:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yong Y, Wu D, Fernandes V, et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002; 89:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lafitte S, Dos Santos P, Kerouani A, et al. Improved reliability for echocardiographic measurement of left ventricular volume using harmonic power imaging mode combined with contrast agent. Am J Cardiol 2000; 85:1234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001; 38:867.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crouse LJ, Cheirif J, Hanly DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial. J Am Coll Cardiol 1993; 22:1494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voci P, Muan B, Morris H, et al. Assessment of left ventricular systolic function in low-echogenic patients by intravenous Infoson injection during dopamine echocardiography. An open, phase III trial. Cardiologia 1997; 42:495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 2009; 53:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leischik R, Kuhlmann C, Bruch C, et al. Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963). Int J Card Imaging 1997; 13:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolan MS, Riad K, El-Shafei A, et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 2001; 142:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolan MS, Gala SS, Dodla S, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol 2009; 53:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005; 112:1444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter TR, Smith LM, Wu J, et al. Patient outcome following 2 different stress imaging approaches: a prospective randomized comparison. J Am Coll Cardiol 2013; 61:2446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas D, Xie F, Smith LM, et al. Prospective randomized comparison of conventional stress echocardiography and real-time perfusion stress echocardiography in detecting significant coronary artery disease. J Am Soc Echocardiogr 2012; 25:1207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shimoni S, Zoghbi WA, Xie F, et al. Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography. J Am Coll Cardiol 2001; 37:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeetley P, Hickman M, Kamp O, et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 2006; 47:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Senior R, Moreo A, Gaibazzi N, et al. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study. J Am Coll Cardiol 2013; 62:1353.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5313 Version 18.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33077502" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Contrast echocardiography: current status and future directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29502588" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34756394" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Agitated Saline Contrast Echocardiography in the Identification of Intra- and Extracardiac Shunts: Connecting the Dots.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26239900" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26765302" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18847480" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Persistent left superior vena cava: a case report and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/114540" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Detection of persistent left superior vena cava by two-dimensional contrast echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6979850" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Computed tomographic demonstration of mediastinal venous anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37077435" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : A Positive Microbubble Study in Ventricular Septal Defect Patient Without Pulmonary Hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28197278" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Patent Ductus Arteriosus With Eisenmenger Syndrome: Difficult Diagnosis Made Easily With Saline Contrast Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10477422" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Evidence of patent ductus arteriosus and right-to-left shunt by finger pulse oxymetry and Doppler signals of agitated saline in abdominal aorta.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33553401" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Dynamic biomechanical effect of lower body positive pressure treadmill training for hemiplegic gait rehabilitation after stroke: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36106537" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18992671" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11897214" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10802007" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Improved reliability for echocardiographic measurement of left ventricular volume using harmonic power imaging mode combined with contrast agent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11527647" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8227810" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9225493" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Assessment of left ventricular systolic function in low-echogenic patients by intravenous Infoson injection during dopamine echocardiography. An open, phase III trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19245974" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9360175" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11685180" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19118722" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16129798" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23643501" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Patient outcome following 2 different stress imaging approaches: a prospective randomized comparison.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22998856" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prospective randomized comparison of conventional stress echocardiography and real-time perfusion stress echocardiography in detecting significant coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11693746" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16386678" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23770168" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
